13F-HR filed by MPM BIOIMPACT LLC
MPM BIOIMPACT LLC filed this 13F-HR for the quarter ended 2021-06-30, filed 2021-08-13, with 14 holding rows worth $608,713,000.
- Accession
- 0000950123-21-010730
- Filer
- CIK 1687078
- Filed
- 2021-08-13
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2021
A holdings report, 14 entries on the cover page, a total value of $608,713,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $608,714,000 with VALUE read as thousands by filing date, 13F file number 028-20107. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| CULLINAN THERAPEUTICS INC | 230031106 | COM | 7,913,887 | $203,783,000 | thousands by filing date | |
| ITEOS THERAPEUTICS INC | 46565G104 | COM | 2,338,581 | $59,985,000 | thousands by filing date | |
| TCR2 THERAPEUTICS INC | 87808K106 | COM | 3,370,982 | $55,318,000 | thousands by filing date | |
| REPARE THERAPEUTICS INC | 760273102 | COM | 1,676,087 | $52,260,000 | thousands by filing date | |
| HARPOON THERAPEUTICS INC | 41358P106 | COM | 3,196,707 | $44,338,000 | thousands by filing date | |
| WEREWOLF THERAPEUTICS INC | 95075A107 | CMN | 2,388,011 | $41,647,000 | thousands by filing date | |
| ONCORUS INC | 68236R103 | COM | 2,377,031 | $32,803,000 | thousands by filing date | |
| MEI Pharma, Inc. | 552798202 | Common | 10,137,859 | $28,893,000 | thousands by filing date | |
| TURNING PT THERAPEUTICS | 90041T108 | COM | 269,186 | $21,002,000 | thousands by filing date | |
| EPIZYME INC | 29428V104 | COM | 2,331,534 | $19,375,000 | thousands by filing date | |
| G1 THERAPEUTICS INC | 3621LQ109 | COM | 812,794 | $17,833,000 | thousands by filing date | |
| MERUS N V | N5749R100 | COM | 700,879 | $14,768,000 | thousands by filing date | |
| Y-mAbs Therapeutics Inc | 984241109 | Common Stock | 337,291 | $11,400,000 | thousands by filing date | |
| ADC THERAPEUTICS SA | H0036K147 | COMMON STOCK | 218,027 | $5,309,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000950123-21-010730 | this filing | 2021-08-13 | acceptance time not in the bulk data set |